Results 171 to 180 of about 184,554 (278)
Case‐Based Immunology: B Cells and Systemic Sclerosis Interstitial Lung Disease
Interstitial lung disease (ILD) is an important complication of systemic sclerosis (SSc), with high mortality and morbidity. Recent clinical studies in SSc‐ILD have led to US Food and Drug Administration–approved therapies in SSc‐ILD. Importantly, evidence from these studies has been extrapolated to guide management of ILDs of other systemic autoimmune
Nina Goldman +2 more
wiley +1 more source
Digital Gangrene and Postoperative Survival Following Lung or Heart-Lung Transplantation in Patients With Systemic Sclerosis. [PDF]
Lee BS +4 more
europepmc +1 more source
Domino heart transplant following heart-lung transplantation: a systematic review and meta-analysis. [PDF]
Maynes EJ +9 more
europepmc +1 more source
Objective Peripheral blood leukocyte telomere length (PBL‐TL) shortening is associated with systemic sclerosis–related interstitial lung disease (SSc‐ILD). However, its association with other organ involvement, disease severity, and survival remains unclear.
Monica M. Yang +6 more
wiley +1 more source
Four decades of heart-lung transplantation: Milestones and outcomes in advanced cardiorespiratory failure. [PDF]
Rosenthal LL +10 more
europepmc +1 more source
Background Beyond its role as a ribosome‐targeting antibiotic, linezolid was recently shown to modulate immune responses by inhibiting mitochondrial translation. Since mitochondrial dysfunction is implicated in various fibrotic diseases, including systemic sclerosis (SSc), this study aimed to evaluate the antifibrotic potential of linezolid and ...
Xuezhi Hong +13 more
wiley +1 more source
Renal Outcomes After Lung or Combined Heart-Lung Transplantation in Pulmonary Hypertension. [PDF]
Hardy L +17 more
europepmc +1 more source
Recent improvement in clinical pancreas transplantation [PDF]
Abendroth, D. +4 more
core +1 more source

